Company profile: Crelux
1.1 - Company Overview
Company description
- Provider of structure-based drug discovery solutions for pharma, biotech, and research organizations, offering protein engineering and production, isotope labeling, custom conjugation, antigen production, structure determination (X-ray crystallography, cryo-EM, NMR), biophysics and biochemistry techniques, fragment-based drug discovery, medicinal chemistry and CADD, and scientific advisory and project management.
Products and services
- Structure Determination: Delivers integrated 3D macromolecular structures via X-ray crystallography, cryo-EM, and NMR, enabling precise target characterization and structure-based discovery for pharma, biotech, and research organizations
- Fragment-Based Drug Discovery: Executes high-throughput fragment screening and crystallography to identify and optimize small-molecule ligands, delivering structure-guided hits for structure-based drug discovery
- CRELUX Protein Services: Supplies customized protein engineering and production, isotope labeling, custom conjugation, and antigen production services for various target classes, delivering tailored proteins for structure-based drug discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Crelux
CancerVax
HQ: United States
Website
- Description: Provider of novel biological products for cancer treatment and control, focused on specific active immunotherapy. Offerings include a Universal Cancer Vaccine (UCV) platform that forces cancer cells to express a unique protein marker for precise immune targeting, a Universal CAR-T (UCAR-T) platform that reprograms natural T-cells inside the body to destroy targeted cancer cells, and an Ewing sarcoma immunotherapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CancerVax company profile →
Boca Biolistics
HQ: United States
Website
- Description: Provider of hybrid CRO and biobank services, delivering human biospecimens across oncology and other diseases; end-to-end contract research to support development and market approval of diagnostic technologies; CLIA-certified, CAP-accredited reference lab testing; COVID-19 serology and PCR; and oncology research solutions combining clinical research, data analytics, and industry leading clinical and molecular datasets to enable precision medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boca Biolistics company profile →
ProductLife
HQ: Belgium
Website
- Description: Provider of regulatory and compliance consulting and outsourcing for pharmaceutical companies; manufacturing and supply chain optimization; operational excellence services; data governance and data model enhancements; IT project management and implementation; and run and service desk support for business-critical applications in the life sciences sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProductLife company profile →
Cellumen
HQ: United States
Website
- Description: Provider of cellular systems biology solutions delivering accurate predictions of drug efficacy and safety to drive Discovery Toxicology and reduce failure rates and development costs. Offers biomarker analysis tools, including for COVID-19 and cardiac issues, cloning, assay kits (ELISA and protein), and cDNA for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellumen company profile →
NEC Med Pharma
HQ: Germany
Website
- Description: Provider of pharmaceutical and medical product sales and marketing services, maintaining a large network between manufacturers of pharmaceutical products and pharmacies. Founded in 2001 and based in Höchstadt, Germany.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NEC Med Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Crelux
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Crelux
2.2 - Growth funds investing in similar companies to Crelux
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Crelux
4.2 - Public trading comparable groups for Crelux
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →